Keyphrases
Acute Phase Response
11%
Acute Respiratory Infection
100%
Antibiotic Resistance
22%
Antibiotic Treatment
44%
Antibiotic Use
100%
Antibiotics
100%
Bacterial Etiology
11%
Biomarker Testing
11%
C-reactive Protein
66%
Causal Link
11%
Chance Finding
11%
CINAHL
11%
Clinical Examination
11%
Clinical Management
11%
Clinical Recovery
11%
Clinical Setting
11%
Cluster Randomized Trial
44%
Confidence Interval
33%
Duration of Illness
11%
Effect Estimates
33%
Embase
11%
Etiology
11%
Extracted Data
11%
Health Care Services
11%
Hospitalization
33%
I(2)
33%
Infection Biomarkers
22%
Infection Markers
11%
Infectious Diseases
11%
Inflammation
11%
Low-to-moderate
11%
MEDLINE
11%
Meta-analysis
11%
Moderate Risk
11%
Non-severe
11%
Observed Heterogeneity
22%
Patient Recovery
11%
Patient Satisfaction
11%
Patient-reported Outcomes
11%
Patients at Risk
11%
Point-of-care
77%
Point-of-care Test
100%
Pooling Effect
11%
Potential Side Effects
11%
Primary Care
100%
Primary Care Patients
11%
Primary Care Setting
11%
Protein Clusters
22%
Random-effects Meta-analysis
11%
Randomized Controlled Trial
33%
Reduction Degree
11%
Review Authors
11%
Risk of Bias
22%
Risk Ratio
33%
Risk-based Design
11%
Savings Method
11%
Standard of Care
22%
Subgroup Analysis
11%
Subgroup Differences
11%
Surrogate Marker
11%
Tissue Injury
11%
Trauma
11%
Unnecessary Antibiotics
22%
Viral
11%
Web of Science
11%
Medicine and Dentistry
Acute Phase Response
12%
Antibiotic Resistance
25%
Antibiotic Therapy
50%
Antibiotics
100%
Biological Marker
100%
C Reactive Protein
75%
Clinical Examination
12%
Clinical Management
12%
Disease Marker
12%
Diseases
12%
Health Care Cost
12%
Infection
75%
Infectious Disease
12%
Injury
12%
Meta-Analysis
25%
Patient Satisfaction
12%
Patient-Reported Outcome
12%
Physician
25%
Primary Health Care
100%
Randomized Controlled Trial
87%
Respiratory Tract Infection
100%
Side Effect
12%
Subgroup Analysis
12%
Tissue Injury
12%
Nursing and Health Professions
Antibiotic Therapy
50%
Antimicrobial Resistance
25%
Biological Marker
100%
C Reactive Protein
75%
CINAHL
12%
Clinical Examination
12%
Clinical Management
12%
Confidence Interval
37%
Disease Marker
12%
Diseases
25%
Health Care
12%
Health Care Quality
25%
Infection
75%
Inflammation
12%
Injury
12%
Meta Analysis
25%
Patient Satisfaction
12%
Patient-Reported Outcome
12%
Physician
25%
Primary Medical Care
100%
Respiratory Tract Infection
100%
Side Effect
12%
Tissue Injury
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Antimicrobial Resistance
25%
Biological Marker
100%
C Reactive Protein
75%
Disease Marker
12%
Diseases
25%
Infection
75%
Inflammation
12%
Injury
12%
Randomized Controlled Trial
87%
Respiratory Tract Infection
100%
Side Effect
12%
Tissue Injury
12%